Drug · DIN 02452154
JETREA
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since March 20, 2020; first marketed May 8, 2019.
- Drug Identification Number (DIN)
- 02452154
- Company (DIN owner)
- Thrombogenics NvLeuven, Flemish Brabant, Belgium
- Schedule
- Schedule d
- Dosage form
- Solution
- Route
- Intravitreal
- Therapeutic class (ATC)
- Ocriplasmin S01XA22
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| OCRIPLASMIN | 1.25 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 27, 2018: NOC 21359New Drug Submission (NDS) · Manufacturer name change
- February 16, 2016: NOC 17778Supplement to a New Drug Submission (SNDS) · New formulation
Other DINs named JETREA
- DIN 02410818 · Cancelled Post Market